PPI Use Is Negative Prognostic Marker in Urothelial Cancer

WEDNESDAY, Sept. 16, 2020 -- For patients with advanced urothelial cancer treated with atezolizumab, proton pump inhibitor (PPI) use is a negative prognostic marker, according to a study published online Sept. 15 in Clinical Cancer Research. Ashley...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news